BONEH — BBS-Bioactive Bone Substitutes Oyj Balance Sheet
0.000.00%
Last trade - 00:00- €9.70m
- €12.48m
Annual balance sheet for BBS-Bioactive Bone Substitutes Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.516 | 3.44 | 1.24 | 1.52 | 1.97 |
| Net Total Receivables | 0.141 | 0.21 | 0.327 | 0.397 | 0.042 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.657 | 3.65 | 1.57 | 1.92 | 2.02 |
| Net Property, Plant And Equipment | 1.28 | 1.2 | 1.15 | 1.02 | 0.901 |
| Net Intangible Assets | |||||
| Total Assets | 9.83 | 12.7 | 10.5 | 10.7 | 10.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.39 | 0.724 | 1.57 | 1.7 | 1.38 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.75 | 6.61 | 6.87 | 6.42 | 5.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3.08 | 6.09 | 3.63 | 4.27 | 5.11 |
| Total Liabilities & Shareholders' Equity | 9.83 | 12.7 | 10.5 | 10.7 | 10.6 |
| Total Common Shares Outstanding |